These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2903451)

  • 1. Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.
    Altar CA; Boyar WC; Wasley A; Gerhardt SC; Liebman JM; Wood PL
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):162-8. PubMed ID: 2903451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.
    Altar CA; Wasley AM; Liebman J; Gerhardt S; Kim H; Welch JJ; Wood PL
    Life Sci; 1986 Aug; 39(8):699-705. PubMed ID: 2874470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC; Altar CA
    J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
    Gerhardt S; Gerber R; Liebman JM
    Life Sci; 1985 Dec; 37(25):2355-63. PubMed ID: 3908866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.
    Sorensen SM; Kehne JH; Fadayel GM; Humphreys TM; Ketteler HJ; Sullivan CK; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1993 Aug; 266(2):684-91. PubMed ID: 8102646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
    Nikulina IuA; Skrinskaia IuA; Popova NK
    Biull Eksp Biol Med; 1988 Aug; 106(8):212-4. PubMed ID: 3262000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1991 Nov; 133(1):77-80. PubMed ID: 1686482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics.
    Gudelsky GA; Meltzer HY
    Neuropsychopharmacology; 1989 Mar; 2(1):45-51. PubMed ID: 2572233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.